Leadership Team | OrthoSensor, Inc.

Leadership

OrthoSensor is led by a committed group of professionals, Executive Leadership and Board of Directors, with numerous years of experience in medical device and technology development. Their passion and vision is what drives OrthoSensor each and every day.

EXECUTIVE LEADERSHIP

 

OrthoSensor’s EXECUTIVE LEADERSHIP is comprised of some of the industry’s most experienced, motivated and innovative decision makers.


IVAN DELEVIC, President & Chief Executive Officer

Ivan Delevic brings a wealth of medical device industry experience to OrthoSensor from his prior leadership roles within Johnson & Johnson, GE Healthcare and most recently as a senior leader at MAKO Surgical where he played a pivotal role in the company’s successful growth and acquisition by Stryker. He has experience both domestically and internationally with previous roles at GE Healthcare including General Manager for Molecular Imaging EMEA, Global Marketing and Sales Manager for Surgical Navigation, Business Development Manager, Six Sigma Leader & Black Belt for Global Functional Imaging, and Sales Manager for Southeastern Europe. Mr. Delevic was also a co-founder of a business where he has served as a business development advisor to numerous medical device companies. He holds a M.B.A. from the Technical University of Budapest through a joint program with Herriot-Watt University and a M.S. in Electrical Engineering from the Technical University of Budapest.


MARTIN ROCHE, MD, Founder & Chief Medical Officer

Dr. Martin Roche is a board certified orthopaedic surgeon at Holy Cross Orthopedic Institute, specializing in reconstructive knee surgery. A pioneer of minimally invasive techniques for joint replacements, robotics and sensor applications, Dr. Roche has served as an international instructor, lecturer and developer of innovative knee devices and surgical approaches. Dr. Roche was a consultant on initial development for MAKO Surgical’s RIO robot and was instrumental in bringing that technology to market. He holds multiple patent applications and continues to focus on integrating advanced technologies into his practice to improve patient outcomes. He has served on multiple clinical advisory boards and as a team physician for the Florida Marlins.


ROMAN BENSEN, Chief Financial Officer

Roman Bensen is a seasoned financial executive with two decades of experience, specializing in strategic finance and corporate performance improvement. His professional experience spans multi-billion dollar public companies and entrepreneurial startups. Mr. Bensen is the former Founder and President of Fidelity Marketing Group and Founder and CEO of Direct Home Capital, both financial services companies. He also has previous investment banking experience with Jefferies & Company’s corporate finance group. Mr. Bensen earned his MBA from Tulane University and holds an MS in Civil Engineering & Environmental Studies, as well as an MS in Electrical Engineering.


STEVE SEGER, Sr. Vice President of Sales and Marketing

Steve Seger joined OrthoSensor in 2015 with more than 20 years of Sales, Marketing and Sales Leadership experience in the Healthcare Industry. Prior to OrthoSensor, he was a member of the Executive Team at Wright Medical/MicroPort Orthopedics where he served as Vice President of North American Sales. He played an instrumental role in the complex conversion of Wright Medical’s Foot & Ankle distributor network to a direct salesforce and then helped lead the successful transition of the Hip & Knee Division acquired by MicroPort. Mr. Seger’s extensive commercial leadership experience also includes leading sales and marketing teams at Jazz Pharmaceuticals, Encysive Biotech, The ICOS Corporation and Merck Human Health. He has a wealth of experience in building sales organizations through active recruiting, hiring and training and then leading those teams to consistently strong sales results. He holds a MBA from Texas Christian University and a BBA from The University of Texas at Austin with a dual degree in Finance and Marketing.


Jack Leo, General Counsel

Jack Leo is an accomplished corporate attorney with strong experience across a broad range of transactions and legal work. Immediately prior to joining OrthoSensor, Jack was a corporate associate at Greenberg Traurig LLP, Florida’s premier corporate law firm. Prior to his time at Greenberg, Jack was a mergers and acquisitions associate at Davis Polk & Wardwell LLP in New York, one of the world’s top law firms. He also served as a law clerk for the Hon. Vice Chancellor J. Travis Laster of the Delaware Court of Chancery, a court that sits at the heart of American corporate governance jurisprudence. Jack graduated magna cum laude and order of the coif with a J.D. from New York University School of Law and with honors with a B.A. from the University of Wisconsin – Madison.


Jonathan Trousdale, Chief Technology Officer

Jonathan Trousdale joined OrthoSensor in 2015 with broad experience in technical, business and legal fields.  Jonathan came to OrthoSensor from Mako Surgical, where he led the company’s intellectual property efforts in the surgical robotics space.  Prior to Mako, he spent time in both private practice and as patent counsel for Caterpillar, where he was deeply embedded in the development of numerous technologies ranging from satellite communications to autonomous operation of heavy equipment.  Jonathan holds an M.B.A from University of Chicago, a J.D. from Vanderbilt University, and a B.S. in Mechanical Engineering from U.C. Berkeley.


BOARD OF DIRECTORS

 

OrthoSensor’s BOARD OF DIRECTORS is a prestigious group of business leaders who work closely to help manage and advise on OrthoSensor’s business affairs.


MICHAEL STANSKY, Chairman

Mr. Stansky was a Managing Director of Tudor Investment Corporation where he was responsible for long/short equity and venture capital investments. He joined Tudor in January 1994 and retired from active investment management in 2008. From 1985 to 1994, Mr. Stansky was an analyst and portfolio manager at Wellington Management Company. He currently advises and serves on the board of directors of several start-up companies including Micell Technologies and Insightec. Mr. Stansky serves on the Investment Committee of Leerink Revelation Partners. He holds a B.A. in Accounting from the University of Massachusetts and a M.B.A. from Harvard Business School. Mr. Stansky is a Certified Public Accountant and a Chartered Financial Analyst.


MARTIN ROCHE, MD

Dr. Martin Roche is a board certified orthopaedic surgeon at Holy Cross Orthopedic Institute, specializing in reconstructive knee surgery. He is the Founder and serves as the Chief Medical Officer of OrthoSensor, Inc. A pioneer of minimally invasive techniques for joint replacements, robotics and sensor applications, Dr. Roche has served as an international instructor, lecturer and developer of innovative knee devices and surgical approaches. Dr. Roche was a consultant on initial development for MAKO Surgical’s RIO robot and was instrumental in bringing that technology to market. He holds multiple patents and continues to focus on integrating advanced technologies into his practice to improve patient outcomes. He has served on multiple clinical advisory boards and as a team physician for the Florida Marlins.


MANUEL AGUERO

Mr. Aguero has over 24 years of experience in the healthcare industry, including eight years at Johnson & Johnson where he held positions of increasing responsibility including sales, marketing and management. Mr. Aguero is Co-founder and President of Q*Med corporation, a medical device distribution company. Mr. Aguero graduated with Honors from The University of Florida with a BSBA in Business Finance. Mr. Aguero is also an active investor and advisor on several start up and private placement vehicles in the healthcare field.


DAVID MATLIN

Mr. Matlin is the Chief Executive Officer of MatlinPatterson Global Advisers LLC, a $9 billion global private equity firm, which he co-founded in July 2002. Prior to forming MatlinPatterson, Mr. Matlin was a Managing Director at Credit Suisse First Boston and head of their Distressed Securities Group since its inception in 1994. Before joining CSFB, Mr. Matlin was Managing Director of distressed securities and a founding partner of Merrion Group, L.P.. Mr. Matlin holds a JD degree from the Law School of the University of California at Los Angeles and a BS in Economics from the Wharton School of the University of Pennsylvania. Mr. Matlin serves on the boards of Flagstar Bancorp, Inc. and CalAtlantic.


CHANG KYU KIM

Mr. Chang Kyu Kim is Executive Managing Director of KTB Network Co., Ltd., a position he has held since 2008.  KTB Network Co. Ltd. is one of the most prominent investment groups in South Korea with over US $11 billion in assets under management.  Mr. Kim further serves as Executive Director of Investment Screening at KTB Investment Group and acts a fund manager for the Korea National Pension Fund.  Mr. Kim has over 23 years of experience in venture investment, with a focus on health care, information technology, financial technology and online-to-offline commerce.  Past deals include leading investments in Corentec and the Korea Bone Bank, which researches and develops artificial joints and biologic material related to bone growth factors, and investments in VivaRepublica and Woowa Brothers.  Over twenty of KTB’s portfolio companies are listed on KOSDAQ, a South Korean stock exchange.  Mr. Kim serves as a Director of ASTA Inc., VivaRepublica, Rainbowbridge World and Mixed Analog Power Solutions.  Mr. Kim holds an M.S. and B.S. in Economics from Yonsei University.


IVAN DELEVIC

Ivan Delevic serves as the President and Chief Executive Officer of OrthoSensor, Inc. Mr. Delevic brings a wealth of medical device industry experience to OrthoSensor from his prior leadership roles within Johnson & Johnson, GE Healthcare and most recently as a senior leader at MAKO Surgical where he played a pivotal role in the company’s successful growth and acquisition by Stryker. He has experience both domestically and internationally with previous roles at GE Healthcare including General Manager for Molecular Imaging EMEA, Global Marketing and Sales Manager for Surgical Navigation, Business Development Manager, Six Sigma Leader & Black Belt for Global Functional Imaging, and Sales Manager for Southeastern Europe. Mr. Delevic was also a co-founder of a business where he has served as a business development advisor to numerous medical device companies. He holds a M.B.A. from the Technical University of Budapest through a joint program with Herriot-Watt University and a M.S. in Electrical Engineering from the Technical University of Budapest.


MARK BAUMGARTNER

Mark Baumgartner joined The Ziegler Companies in 1984. For the past nine years, he has served as a Chief Investment and Risk Officer/Senior Managing Director. Prior to that, he worked as an investment banker in the healthcare industry, providing capital for hospitals, health systems and large multispecialty group practices. In addition, Mr. Baumgartner’s activities have included mergers, acquisition and financial advisory work.

He currently serves as a member of the Board of Trustees of Physicians Realty Trust, a real estate investment trust trading on the New York Stock Exchange under the symbol DOC. This organization specializes in the acquisition of medical office buildings throughout the United States.

Mark has a B.B.A. in Finance from the University of Notre Dame and is a member of the Healthcare Financial Management Association.


Send this to friend